ADPT Competitors & Alternatives
Compare Adaptive Biotechnologies Corp with similar stocks in the same industry
Diagnostics & Research
ADPT
Main Stock$21.23
Tradestie Score
60
Market Cap
$2.22B
Revenue Growth
0.4%
Analyst Upside
-3.1%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SHC
Sotera Health Company Common Stock
|
$18.34
|
$4.60B | 42.8 | 57 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$64.78
|
$3.26B | - | 56 | Compare |
|
VCYT
Veracyte, Inc.
|
$57.27
|
$2.85B | 52.0 | 60 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$31.07
|
$2.44B | - | 50 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$72.20
|
$2.24B | - | 61 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$91.20
|
$1.77B | - | 59 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$42.33
|
$1.54B | - | 54 | Compare |
|
NEOG
Neogen Corp
|
$9.58
|
$1.26B | - | 61 | Compare |
|
OPK
Opko Health Inc.
|
$1.29
|
$1.23B | - | 54 | Compare |
|
NEO
NeoGenomics, Inc.
|
$14.14
|
$1.13B | - | 58 | Compare |
More ADPT Analysis
Data updated: Jul 13, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry